Oxford Immunotec reports strong revenue; still posts loss
Oxford Immunotec, with its U.S. headquarters in Marlborough, posted 27 percent revenue growth for 2015, but still fell short of analysts’ expectations with a loss of 29 cents per share in the fourth quarter.
The company’s fourth quarter revenue of $16.8 million represented 39 percent year-over-year growth and pushed the company to $62.8 million in revenue for the year. However, the commercial-stage diagnostics company still reported a net loss for the year of $24.5 million. This was up from $22.2 million for 2014 and represented a loss per share of $1.12.
Operating expenses for 2015 rose by $10 million over the previous year to $57.4 million, primarily due to the company expanding its sales force in the U.S. and Japan. Legal fees and costs from clinical studies also increased during the year.
WBJ Web Partners
Most Recent
Most Recent
0 Comments